Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis. [electronic resource]
- Antimicrobial agents and chemotherapy Jan 2015
- 444-9 p. digital
Publication Type: Journal Article
1098-6596
10.1128/AAC.04438-14 doi
Amikacin--therapeutic use Antibiotics, Antitubercular--therapeutic use Capreomycin--therapeutic use Drug Resistance, Multiple, Bacterial--genetics Humans Kanamycin--therapeutic use Microbial Sensitivity Tests--methods Mutation Mycobacterium tuberculosis--drug effects Tuberculosis, Multidrug-Resistant--drug therapy